Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.

Rice G.I., del Toro Duany Y., Jenkinson E.M., Forte G.M., Anderson B.H., Ariaudo G., Bader-Meunier B., Baildam E.M., Battini R., Beresford M.W., Casarano M., Chouchane M., Cimaz R., Collins A.E., Cordeiro N.J., Dale R.C., Davidson J.E., De Waele L., Desguerre I., Faivre L., Fazzi E., Isidor B., Lagae L., Latchman A.R., Lebon P., Li C., Livingston J.H., Lourenco C.M., Mancardi M.M., Masurel-Paulet A., McInnes I.B., Menezes M.P., Mignot C., O'Sullivan J., Orcesi S., Picco P.P., Riva E., Robinson R.A., Rodriguez D., Salvatici E., Scott C., Szybowska M., Tolmie J.L., Vanderver A., Vanhulle C., Vieira J.P., Webb K., Whitney R.N., Williams S.G., Wolfe L.A., Zuberi S.M., Hur S., Crow Y.J.

The type I interferon system is integral to human antiviral immunity. However, inappropriate stimulation or defective negative regulation of this system can lead to inflammatory disease. We sought to determine the molecular basis of genetically uncharacterized cases of the type I interferonopathy Aicardi-Goutières syndrome and of other undefined neurological and immunological phenotypes also demonstrating an upregulated type I interferon response. We found that heterozygous mutations in the cytosolic double-stranded RNA receptor gene IFIH1 (also called MDA5) cause a spectrum of neuroimmunological features consistently associated with an enhanced interferon state. Cellular and biochemical assays indicate that these mutations confer gain of function such that mutant IFIH1 binds RNA more avidly, leading to increased baseline and ligand-induced interferon signaling. Our results demonstrate that aberrant sensing of nucleic acids can cause immune upregulation.

Nat. Genet. 46:503-509(2014) [PubMed] [Europe PMC]

UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again